stock
ACAD · ACADIA PHARMACEUTICALS INC
What ACADIA PHARMACEUTICALS INC reports to the SEC, read from its filings.
Open in the appPrice
The live ACAD price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on ACAD.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 172,305,518 as of 2026-07-28 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- 7.6%
- Net
- 33.4%
Returns
- ROE
- 29.1%
- ROA
- 21.8%
Health
- Current ratio
- 3.4x
- Debt/equity
- —
Deep value
- NCAV
- $788.25M
- NCAV per share
- $4.57
- Price/NCAV
- Locked
- NNWC
- $116.01M
- NNWC per share
- $0.67
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $307.96M | — | $37.84M | $31.50M | 10-Q filed 2026-08-05 |
| 2026-03-31 | $268.06M | — | -$4.62M | $3.64M | 10-Q filed 2026-05-07 |
| 2025-12-31 | $283.99M | — | $17.39M | $273.57M | DEF 14A filed 2026-04-24 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $278.63M | — | $35.76M | $71.78M | 10-Q filed 2025-11-06 |
| 2025-06-30 | $264.57M | — | $32.37M | $26.67M | 10-Q filed 2026-08-05 |
| 2025-03-31 | $244.32M | — | $19.29M | $18.99M | 10-Q filed 2026-05-07 |
| 2024-12-31 | $259.60M | — | $153.50M | $143.29M | DEF 14A filed 2026-04-24 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $250.40M | — | $31.64M | $32.77M | 10-Q filed 2025-11-06 |
- Assets
- $1.74B
- Equity
- $1.31B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $1.07B | $104.81M | $391.00M | $105.15M |
| 2024-12-31 | $957.80M | $230.79M | $226.00M | $157.20M |
| 2023-12-31 | $726.44M | -$73.38M | -$61.00M | $16.65M |
| 2022-12-31 | $517.24M | -$223.60M | -$214.00M | -$114.03M |
| 2021-12-31 | $484.14M | -$170.44M | -$168.00M | -$126.78M |
| 2020-12-31 | $441.75M | -$286.59M | -$281.58M | -$143.75M |
| 2019-12-31 | $339.08M | -$246.54M | -$235.26M | -$152.26M |
| 2018-12-31 | $223.81M | -$247.44M | -$245.19M | -$169.57M |
| 2017-12-31 | $124.90M | -$292.41M | -$289.40M | -$218.57M |
| 2016-12-31 | $17.33M | -$272.81M | -$271.39M | -$209.91M |
Company filings
events
Regulation FD disclosure, Other event
Regulation FD disclosureOther eventSep 248-KOther event
Other eventSep 118-KResults
ResultsAug 48-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsMay 298-KResults
ResultsMay 68-KExecutive or director change, Regulation FD disclosure
Executive or director changeRegulation FD disclosureApr 308-K
5% owners ()
STATE STREET CORPORATION
Passive stake
Vanguard Portfolio Management
Passive stake
The Vanguard Group
Stake update
Baker Bros. Advisors LP
Stake update
RTW Investments, LP
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Sale$587,242Aug 7, 6:00 PM ET
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
Sale$432,663Jul 31, 6:00 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Point72
Period Tue 30 Jun 2026
0.1%Trimmed - Bridgewater Associates
Period Tue 30 Jun 2026
0.0%Trimmed - Point72
Calls · Period Tue 30 Jun 2026
0.0%Added - Point72
Puts · Period Tue 30 Jun 2026
0.0%Added
News
Stories that named ACAD, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about ACAD.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on ACAD come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the ACAD board